Indeed, in vitro studies previously showed that IFNβ induced the release of the anti-inflammatory cytokine IL-10 from lymphocytes acquired from patients with MS [62, 63], which might indicate that IFNβ could eventually induce an anti-inflammatory response in the colonic mucosa as well. Here, IFNB1 is linked to myeloid sarcoma.